|
US7767449B1
(en)
|
1981-12-24 |
2010-08-03 |
Health Research Incorporated |
Methods using modified vaccinia virus
|
|
US5505941A
(en)
*
|
1981-12-24 |
1996-04-09 |
Health Research, Inc. |
Recombinant avipox virus and method to induce an immune response
|
|
US7374768B1
(en)
|
1990-09-25 |
2008-05-20 |
Xenova Research Limited |
Viral vaccines
|
|
US6309647B1
(en)
*
|
1999-07-15 |
2001-10-30 |
Aventis Pasteur |
Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
|
|
DE69229390T2
(de)
|
1991-08-26 |
1999-11-11 |
Immuno Ag, Wien |
Direkt molekuläre Klonierung eines modifizierten Genoms eines Chordopocken-Virus
|
|
JP3911010B2
(ja)
*
|
1994-04-29 |
2007-05-09 |
イムノ・アクテイエンゲゼルシヤフト |
必須領域に外来ポリヌクレオチドを有する組換えポックスウイルス
|
|
FR2750865B1
(fr)
*
|
1996-06-27 |
1998-12-04 |
Rhone Merieux |
Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2
|
|
US7294338B2
(en)
*
|
1996-07-19 |
2007-11-13 |
Merial |
Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
|
|
US6368603B1
(en)
*
|
1997-03-05 |
2002-04-09 |
Merial Limited |
Lyme combination compositions and uses
|
|
US6517843B1
(en)
|
1999-08-31 |
2003-02-11 |
Merial |
Reduction of porcine circovirus-2 viral load with inactivated PCV-2
|
|
FR2775601B1
(fr)
*
|
1998-03-03 |
2001-09-21 |
Merial Sas |
Vaccins vivants recombines et adjuves
|
|
US6497883B1
(en)
|
1999-06-10 |
2002-12-24 |
Merial |
Porcine circovirus recombinant poxvirus vaccine
|
|
EP1228095B1
(en)
|
1999-10-22 |
2008-04-09 |
Sanofi Pasteur Limited |
Modified gp100 and uses thereof
|
|
DK1248646T3
(da)
*
|
1999-12-21 |
2008-05-19 |
Merial Sas |
Præparater og vacciner indeholdende antigen(er) fra cryptosporidium parvum og fra andet enterisk patogen
|
|
US20030027246A1
(en)
*
|
2000-03-31 |
2003-02-06 |
Artur Pedyczak |
Immunogenic peptides derived from prostate-specific membrane antigen (PSMA) and uses thereof
|
|
US7851212B2
(en)
|
2000-05-10 |
2010-12-14 |
Sanofi Pasteur Limited |
Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
|
|
PT1335987E
(pt)
|
2000-11-23 |
2006-05-31 |
Bavarian Nordic As |
Variante do virus vacina modificado ancara
|
|
US7628980B2
(en)
*
|
2000-11-23 |
2009-12-08 |
Bavarian Nordic A/S |
Modified vaccinia virus ankara for the vaccination of neonates
|
|
US7097842B2
(en)
*
|
2000-11-23 |
2006-08-29 |
Bavarian Nordic A/S |
Modified vaccinia virus ankara for the vaccination of neonates
|
|
FR2823222B1
(fr)
|
2001-04-06 |
2004-02-06 |
Merial Sas |
Vaccin contre le virus de la fievre du nil
|
|
US20030228327A1
(en)
*
|
2001-11-05 |
2003-12-11 |
Lasher Alfred W. |
DNA-based plasmid formulations and vaccines and prophylactics containing the same
|
|
US20070269456A1
(en)
*
|
2001-11-05 |
2007-11-22 |
Lasher Alfred W |
DNA-based plasmid formulations and vaccines and prophylactics containing the same
|
|
IL163701A0
(en)
*
|
2002-04-19 |
2005-12-18 |
Bavarian Nordic As |
Modified vaccinia virus ankara for the vaccinationof neonates
|
|
JP2006511194A
(ja)
|
2002-05-02 |
2006-04-06 |
デイビッド ラブジョイ |
テネウリンｃ末端関連ペプチド（ｔｃａｐ）並びにこれらに関連する方法および使用
|
|
EP1434858B2
(en)
*
|
2002-09-05 |
2018-12-19 |
Bavarian Nordic A/S |
Method for the amplification of a poxvirus under serum free conditions
|
|
CA2510229A1
(en)
*
|
2002-12-13 |
2004-07-08 |
Aventis Pasteur, Inc. |
Production of alvac on avian embryonic stem cells
|
|
CA2510309C
(en)
*
|
2002-12-16 |
2014-09-16 |
Liyange P. Perera |
Recombinant vaccine viruses expressing il-15 and methods of using the same
|
|
US7468273B2
(en)
|
2003-05-01 |
2008-12-23 |
Meial Limited |
Canine GHRH gene, polypeptides and methods of use
|
|
US20060240039A1
(en)
*
|
2003-06-13 |
2006-10-26 |
Isis Innovation Limited |
Vaccines
|
|
JP5576010B2
(ja)
|
2003-08-04 |
2014-08-20 |
ザ・ホスピタル・フォー・シック・チルドレン |
ラフォラ病遺伝子
|
|
ES2417019T3
(es)
|
2003-11-13 |
2013-08-05 |
University Of Georgia Research Foundation, Inc. |
Procedimiento de caracterización del virus de la enfermedad de la bursitis infecciosa
|
|
CA2580305A1
(en)
*
|
2004-06-02 |
2005-12-15 |
The Governors Of The University Of Alberta |
Polymer based nano-carriers for the solubilization and delivery of hydrophobic drugs
|
|
US7998733B2
(en)
|
2004-10-05 |
2011-08-16 |
Merial Limited |
Chimeric vectors
|
|
ATE461710T1
(de)
|
2005-04-25 |
2010-04-15 |
Merial Ltd |
Nipah-virus-impfstoffe
|
|
US20080241184A1
(en)
|
2005-08-25 |
2008-10-02 |
Jules Maarten Minke |
Canine influenza vaccines
|
|
US7771995B2
(en)
|
2005-11-14 |
2010-08-10 |
Merial Limited |
Plasmid encoding human BMP-7
|
|
EP2186823A1
(en)
|
2005-11-14 |
2010-05-19 |
Merial Limited |
Gene therapy for renal failure
|
|
EP2759307B1
(en)
|
2006-03-29 |
2016-11-09 |
Merial Limited |
Vaccine against Streptococci
|
|
US7682619B2
(en)
|
2006-04-06 |
2010-03-23 |
Cornell Research Foundation, Inc. |
Canine influenza virus
|
|
US7862821B2
(en)
|
2006-06-01 |
2011-01-04 |
Merial Limited |
Recombinant vaccine against bluetongue virus
|
|
JP2010510992A
(ja)
*
|
2006-11-30 |
2010-04-08 |
ユニバーシティー オブ ブリティッシュ コロンビア |
分子アジュバンドとしてのｔａｐ−１及び／又はｔａｐ−２を含むポックスウイルスの治療
|
|
BRPI0721630A2
(pt)
|
2007-05-02 |
2013-10-15 |
Merial Ltd |
Plasmídeo de dna tendo expressão e estabilidade aperfeiçoadas
|
|
CN103768588A
(zh)
|
2008-05-08 |
2014-05-07 |
梅里亚有限公司 |
使用白蛉唾液免疫原的利什曼原虫疫苗
|
|
EP4019529A1
(en)
|
2008-06-27 |
2022-06-29 |
MicroSintesis Inc. |
Probiotic bacterial molecules and their use in methods to treat/prevent infection by harmful bacteria and to provide nutritional health
|
|
CN102245627A
(zh)
|
2008-10-24 |
2011-11-16 |
梅里亚有限公司 |
针对非洲马疫病毒的疫苗
|
|
EP3205353B1
(en)
|
2011-03-21 |
2021-01-13 |
Altimmune Inc. |
Rapid and prolonged immunologic-therapeutic
|
|
US9216213B2
(en)
|
2011-04-20 |
2015-12-22 |
Merial, Inc. |
Adjuvanted rabies vaccine with improved viscosity profile
|
|
CA2837375C
(en)
|
2011-06-01 |
2019-07-16 |
Merial Limited |
Needle-free administration of prrsv vaccines
|
|
DK2734230T3
(en)
|
2011-07-20 |
2019-01-28 |
Merial Ltd |
RECOMBINANT FELINE LEUKEMIA VIRUS VACCINE CONTAINING OPTIMIZED FELINE LEUKEMIA VIRUS ENVELOPE GENE
|
|
HUE035774T2
(en)
|
2011-08-12 |
2018-05-28 |
Merial Inc |
Biological substances, in particular vaccines, preserved by vacuum
|
|
US9402894B2
(en)
|
2011-10-27 |
2016-08-02 |
International Aids Vaccine Initiative |
Viral particles derived from an enveloped virus
|
|
BR112014020019A8
(pt)
|
2012-02-14 |
2022-07-12 |
Merial Ltd |
vetores poxvirais recombinantes expressando tanto proteínas da raiva e ox40 e vacinas feitas a partir destes
|
|
EP2827897B1
(en)
|
2012-03-20 |
2018-10-31 |
Merial, Inc. |
Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof
|
|
CA2868575C
(en)
|
2012-03-27 |
2022-11-01 |
The University Of Western Ontario |
Sh2 domain variants
|
|
US9347065B2
(en)
|
2012-03-29 |
2016-05-24 |
International Aids Vaccine Initiative |
Methods to improve vector expression and genetic stability
|
|
EP2968435B1
(en)
|
2013-03-12 |
2019-01-30 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Synthetic peptides for the treatment of autoimmune diseases
|
|
NZ731659A
(en)
|
2014-11-03 |
2018-10-26 |
Merial Inc |
Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
|
|
EP3042666A1
(en)
|
2015-01-06 |
2016-07-13 |
Rheinisch-Westfälische Technische Hochschule Aachen |
ITIH5 fragments for the treatment of cancer
|
|
MY196135A
(en)
|
2015-04-28 |
2023-03-16 |
Avivagen Inc |
Oxidized Carotenoids and Components Thereof for Preventing Necrotic Enteritis
|
|
US20210299245A1
(en)
*
|
2020-03-31 |
2021-09-30 |
Sementis Limited |
Attenuated poxvirus vector based vaccine for protection against covid-19
|
|
CN116656730B
(zh)
*
|
2023-05-25 |
2024-03-19 |
军事科学院军事医学研究院军事兽医研究所 |
一种表达狂犬病病毒g、m蛋白的重组金丝雀痘病毒及其构建方法
|